Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Prepaid Assets: 2020-2024

Historic Prepaid Assets for Mirum Pharmaceuticals (MIRM) over the last 5 years, with Dec 2024 value amounting to $11.8 million.

  • Mirum Pharmaceuticals' Prepaid Assets rose 98.01% to $23.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.9 million, marking a year-over-year increase of 98.01%. This contributed to the annual value of $11.8 million for FY2024, which is 7.76% up from last year.
  • According to the latest figures from FY2024, Mirum Pharmaceuticals' Prepaid Assets is $11.8 million, which was up 7.76% from $10.9 million recorded in FY2023.
  • In the past 5 years, Mirum Pharmaceuticals' Prepaid Assets registered a high of $11.8 million during FY2024, and its lowest value of $4.5 million during FY2020.
  • For the 3-year period, Mirum Pharmaceuticals' Prepaid Assets averaged around $10.6 million, with its median value being $10.9 million (2023).
  • Data for Mirum Pharmaceuticals' Prepaid Assets shows a peak YoY skyrocketed of 69.74% (in 2022) over the last 5 years.
  • Yearly analysis of 5 years shows Mirum Pharmaceuticals' Prepaid Assets stood at $4.5 million in 2020, then increased by 16.36% to $5.3 million in 2021, then surged by 69.74% to $8.9 million in 2022, then climbed by 22.22% to $10.9 million in 2023, then increased by 7.76% to $11.8 million in 2024.